GlassScriptPhysician profile
Seth M Katzen
NPI 1164942223
$28,715.77
in general payments reported to CMS, 2019-2025
24 companies · $4,618 in 2025
The $4,618 reported for 2025 was more than what 94% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2021: $11K · 2022: $1,799 · 2023: $6,622 · 2024: $4,802 · 2025: $4,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $3,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,353.51 |
| Travel and Lodging | $3,688.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,527.41 | 2021-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $8,401.87 | 2021-2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Abbott Laboratories | $3,834.49 | 2021-2025 | Proclaim, Eterna, Octrode |
| Saluda Medical Americas, INC. | $2,821.74 | 2023-2025 | Evoke Scs, Evoke |
| Curonix LLC | $641.51 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $426.56 | 2021-2024 | Senza |
| Vertos Medical, INC. | $323.90 | 2021-2024 | Mild Device Kit |
| Painteq LLC | $230.53 | 2023-2024 | Painteq |
| Forte Bio-Pharma LLC | $183.89 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Stimwave Technologies Incorporated | $170.84 | 2019-2021 | |
| Stryker Corporation | $162.26 | 2024-2025 | Mild Device Kit |
| Nalu Medical, INC. | $148.67 | 2021-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $136.31 | 2024 | Sprint Pns System |
| Si-Bone, INC. | $134.54 | 2024-2025 | |
| Relievant Medsystems, INC. | $126.99 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $109.33 | 2025 | Reactiv8 |
| Trice Medical, INC. | $75.91 | 2022 | |
| Foundation Fusion Solutions, LLC | $72.51 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $42.06 | 2024-2025 | Belbuca |
| Abbvie INC. | $38.46 | 2023 | |
| Avanos Medical | $33.05 | 2022 | |
| Depuy Synthes Sales INC. | $27.11 | 2025 | Orthovisc |
| Amgen INC. | $25.50 | 2024 | Evenity, Prolia |
| Scilex Pharmaceuticals INC. | $20.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Katzen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.